intensity-modulated radiotherapy

Open Access
Efficacy of Multimodality Approach in Patients With Recurrent Head and Neck Squamous Cell Carcinoma
PASCALE ALICIA HOELL, KHALED ELSAYAD, HENDRIK BERSSENBRUEGGE, DOMINIK HERING, CHRISTOPHER KITTEL, JOHANNES KLEINHEINZ, ANNALEN BLECKMANN, GEORG EVERS, EVA WARDELMANN, CLAUDIA RUDACK and HANS THEODOR EICH

Anticancer Research March 2023, 43 (3) 1255-1263; DOI: https://doi.org/10.21873/anticanres.16272
You have access
Definitive Radiotherapy Using Electron Beam and Intensity-modulated Radiotherapy for Unresectable Angiosarcoma of the Scalp
NAOKO OKANO, HIKARU YUMISAKI, SHINTARO SAITO, NOBUTERU KUBO, KOHEI OKADA, HIDEMASA KAWAMURA, MASAHITO YASUDA and TATSUYA OHNO

Anticancer Research December 2022, 42 (12) 5991-5997; DOI: https://doi.org/10.21873/anticanres.16110
You have access
Photon-based High-dose Single-fraction Radiosurgery, an Effective Treatment Modality for Large and Posterior Uveal Melanoma
CONCETTA LALISCIA, FEDERICA GENOVESI-EBERT, FRANCO PERRONE, FRANCESCA GUIDO, FEDERICA CRESTI, TAIUSHA FUENTES, NATALINA COCCIA, ROBERTO MATTIONI, RICCARDO MORGANTI and FABIOLA PAIAR

Anticancer Research April 2022, 42 (4) 1965-1972; DOI: https://doi.org/10.21873/anticanres.15674
You have access
Plan Quality Comparisons Between 3D-CRT, IMRT, and VMAT Based on 4D-CT for Gastric MALT Lymphoma
TADASHI MATSUMOTO, RYO TOYA, YOSHINOBU SHIMOHIGASHI, TAKAHIRO WATAKABE, TOMOHIKO MATSUYAMA, TETSUO SAITO, YOSHIYUKI FUKUGAWA, YUDAI KAI and NATSUO OYA

Anticancer Research August 2021, 41 (8) 3941-3947; DOI: https://doi.org/10.21873/anticanres.15190
You have access
Simultaneous Integrated Radiotherapy Boost to the Dominant Intraprostatic Lesion: Final Results of a Phase I/II Trial
MILLY BUWENGE, ANNA RITA ALITTO, SAVINO CILLA, ILARIA CAPOCACCIA, ERCOLE MAZZEO, EDY IPPOLITO, GIOVANNA MANTINI, GIAMBATTISTA SIEPE, LETIZIA CAVALLINI, VINCENZO VALENTINI, FRANCESCO DEODATO, ALESSIO G. MORGANTI and GABRIELLA MACCHIA

Anticancer Research November 2020, 40 (11) 6499-6503; DOI: https://doi.org/10.21873/anticanres.14672
You have access
Radiotherapy Dose and Volume De-escalation in Ocular Adnexal Lymphoma
STEPHAN REHN, KHALED ELSAYAD, MICHAEL OERTEL, ANDREA BAEHR, NICOLE ETER, UWE HAVERKAMP, GEORG LENZ and HANS THEODOR EICH

Anticancer Research July 2020, 40 (7) 4041-4046; DOI: https://doi.org/10.21873/anticanres.14400
You have access
Comparison of Dose Distributions When Using Carbon Ion Radiotherapy Versus Intensity-modulated Radiotherapy for Hepatocellular Carcinoma With Macroscopic Vascular Invasion: A Retrospective Analysis
SHINTARO SHIBA, KEI SHIBUYA, MOTOHIRO KAWASHIMA, NAOKO OKANO, TAKUYA KAMINUMA, MASAHIKO OKAMOTO, YOSHIKI KUBOTA, TAKASHI NAKANO and TATSUYA OHNO

Anticancer Research January 2020, 40 (1) 459-464; DOI: https://doi.org/10.21873/anticanres.13974
You have access
Effectiveness of Intensity-Modulated Radiotherapy for Rectal Cancer Patients Treated With Neoadjuvant Concurrent Chemoradiotherapy: A Population-based Propensity Score-matched Analysis
CHIA-CHIN LI, JI-AN LIANG, CHIH-YUAN CHUNG, WILLIAM TZU-LIANG CHEN and CHUN-RU CHIEN

Anticancer Research March 2019, 39 (3) 1479-1484; DOI: https://doi.org/10.21873/anticanres.13265
You have access
Quality of Life and Radiation-induced Late Toxicity Following Intensity-modulated Versus Three-dimensional Conformal Radiotherapy for Patients with Spinal Bone Metastases: Results of a Randomized Trial
TANJA SPRAVE, VIVEK VERMA, ROBERT FÖRSTER, INGMAR SCHLAMPP, KATHARINA HEES, THOMAS BRUCKNER, TILMAN BOSTEL, RAMI EL SHAFIE, NILS HENRIK NICOLAY, JÜRGEN DEBUS and HARALD RIEF

Anticancer Research August 2018, 38 (8) 4953-4960; DOI: https://doi.org/10.21873/anticanres.12813
You have access
Long-term Outcomes of Radiotherapy Regimen of 72 Gy in 30 Fractions for Prostate Cancer
KEISUKE TAMARI, RYOONG-JIN OH, NORIHISA MASAI, HIROYA SHIOMI, KEISUKE OTANI, OSAMU SUZUKI and KAZUHIKO OGAWA

Anticancer Research July 2018, 38 (7) 4207-4212; DOI: https://doi.org/10.21873/anticanres.12716

Main menu

User menu

Search

intensity-modulated radiotherapy

Pages